Therefore, we hypothesized that cinobufacini may interfere with PSCs through the TGFβ/Smads pathway and further affect the pancreatic cancer microenvironment, thereby inhibiting the progression of pancreatic cancer. The gene discussed is TGFB1; the disease is familial pancreatic carcinoma.